Nucleic Acids ResearchGenomicsPeer-reviewed journal article
APSiC: Analysis of Perturbation Screens for the Identification of Novel Cancer Genes
Hesam MontazeriiD, Mairene Coto‐LlerenaiD, Gaia Bianco, Ehsan ZangeneiD, Stephanie Taha‐MehlitziD, Viola Paradiso, Sumana SrivatsaiD, Antoine de WeckiD, Guglielmo RomaiD, Manuela LanzafameiD, Martin BolliiD, Niko BeerenwinkeliD, Markus von Flüe, Luigi TerraccianoiD, Salvatore PiscuoglioiD, Charlotte K.Y. NgiD
Abstract
BackgroundSystematic perturbation screens provide comprehensive resources for the elucidation of cancer driver genes, including rarely mutated genes that are missed by approaches focused on frequently mutated genes and driver genes for which the basis for oncogenicity is non-genetic. The perturbation of many genes in relatively few cell lines in such functional screens necessitates the development of specialized computational tools with sufficient statistical power. ResultsHere we developed APSiC (Analysis of Perturbation Screens for identifying novel Cancer genes) that can identify genetic and non-genetic drivers even with a limited number of samples. Applying APSiC to the large-scale deep shRNA screen Project DRIVE, APSiC identified well-known, pan-cancer genetic drivers, novel putative genetic drivers known to be dysregulated in specific cancer types and the context dependency of mRNA-splicing between cancer types. Additionally, APSiC discovered a median of 28 and 35 putative non-genetic oncogenes and tumor suppressor genes, respectively, for individual cancer types, including genes involved in genome stability maintenance and cell cycle. We functionally demonstrated that LRRC4B, a putative non-genetic tumor suppressor gene that has not previously been associated with carcinogenesis, suppresses proliferation by delaying cell cycle and modulates apoptosis in breast cancer. ConclusionWe demonstrate APSiC is a robust statistical framework for discovery of novel cancer genes through analysis of large-scale perturbation screens. The analysis of DRIVE using APSiC is provided as a web portal and represents a valuable resource for the discovery of novel cancer genes.
- organism: human
- assay: CRISPR screen
- research focus: drug response / drug discovery
- research focus: benchmarking
- research focus: variant effect prediction
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 7
- FWCI
- 0.40
- Field percentile
- 46th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
Sumana Srivatsa, Hesam Montazeri, … Niko Beerenwinkel·Nature CommunicationsPeer-reviewed·Dec 14, 2022
- CRISPR-enabled genetic screens identify synthetic lethal targets across frequently altered cancer drivers
Jessica Desjardins, Julian Bowlan, … Jordan T.F. Young·bioRxiv·Jan 25, 2026
- CancerMine: A literature-mined resource for drivers, oncogenes and tumor suppressors in cancer
Jake Lever, Eric Y. Stutheit-Zhao, … Steven J.M. Jones·Nature MethodsPeer-reviewed·May 20, 2019
- An integrative approach uncovers genes with perturbed interactions in cancers
Shilpa N. Kobren, Bernard Chazelle, Mona Singh·bioRxiv·Aug 13, 2019
- Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions
C. J. Lord, N. Quinn, C. J. Ryan·bioRxiv·Jan 11, 2020
- Pan-cancer detection of driver genes at the single-patient resolution
J. Nulsen, H. Misetic, … F. D. Ciccarelli·bioRxiv·Jun 12, 2020